Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia

Hypertension in Pregnancy

Volumn 30, Issue 2, 2011, Pages 153-163

  Carr, Darcy B ^a   Newton, Katherine M ^b,c   Utzschneider, Kristina M ^a   Faulenbach, Mirjam V ^a   Kahn, Steven E ^a   Easterling, Thomas R ^a   Heckbert, Susan R ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Gestational diabetes; Glucose tolerance; Preeclampsia

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PRIMIGRAVIDA; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES; RISK;

EID: 79953707640     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903115012     Document Type: Article

References (52)

1. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000; 95:24-28. (Pubitemid 30001623)
2. Cunningham F, Lindheimer M. Hypertension in pregnancy. N Engl J Med 1992; 326:927-932.
3. Sibai B, Ewell M, Levine R, et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997; 177:1003-1010. (Pubitemid 27525346)
4. Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL. Risk factors for severe preeclampsia. Obstet Gynecol 1994; 83:357-361. (Pubitemid 24067802)
5. D'Anna R, Baviera G, Corrado F, et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 2006; 113:1264-1269. (Pubitemid 44581516)
6. Parretti E, Lapolla A, Dalfra M, et al. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 2006; 47:449-453. (Pubitemid 43740289)
7. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999; 48:892-896. (Pubitemid 29310046)
8. Emery SP, Levine RJ, Qian C, et al. Twenty-four-h urine insulin as a measure of hyperinsulinaemia/ insulin resistance before onset of pre-eclampsia and gestational hypertension. BJOG 2005; 112:1479-1485. (Pubitemid 43961233)
9. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease with 48 h post partum. Am J Obstet Gynecol 1996; 174:975-982. (Pubitemid 26111679)
10. Sacks G, Studena K, Sargent I, Redman C. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179:80-86. (Pubitemid 28394477)
11. Williams MA, Farrand A, Mittendorf R, et al. Maternal second trimester serum tumor necrosis factor-a soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149:323-329. (Pubitemid 29302104)
12. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 2005; 25:2243-2244. (Pubitemid 41552637)
13. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53:693-700. (Pubitemid 38270639)
14. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes 1997; 46:701-710. (Pubitemid 27143390)
15. Callaway LK, Lawlor DA, O'Callaghan M, Williams GM, Najman JM, McIntyre HD. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: Findings from a prospective cohort study. Am J Obstet Gynecol 2007; 197:492 e1-497 e1.
16. Libby G, Murphy DJ, McEwan NF, et al. Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: An intergenerational study from the Walker cohort. Diabetologia 2007; 50:523-530. (Pubitemid 46215493)
17. Chesley LC. Remote prognosis after eclampsia. Perspect Nephrol Hypertens 1976; 5:31-40.
18. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002; 51:2170-2178. (Pubitemid 34729022)
19. American Diabetes Association: Clinical Practice Recommendations 2006. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29:S43-S48.
20. McLaughlin G, Cheng Y, Caughey A. Women with one elevated 3-h glucose tolerance test value: Are they at risk for adverse perinatal outcomes? Am J Obstet Gynecol 2006; 194:e16-e19.
21. Innes K, Wimsatt J, McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 2001; 97:905-910. (Pubitemid 32522486)
22. Joffe GM, Esterlitz JR, Levine RJ, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1998; 179:1032-1037. (Pubitemid 28489303)
23. Suhonen L, Teramo K. Hypertension and pre-eclampsia in women with gestational glucose intolerance. Acta Obstet Gynecol Scand 1993; 72:269-272. (Pubitemid 23265623)
24. Solomon C, Graves S, Greene M, Seely E. Glucose intolerance as a predictor of hypertension in pregnancy. Hypertension 1994; 23:717-721. (Pubitemid 24180801)
25. Sermer M, Naylor D, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. Am J Obstet Gynecol 1995; 173:146-156.
26. Long PA, Abell DA, Beischer NA. Importance of abnormal glucose tolerance (hypoglycaemia and hyperglycaemia) in the aetiology of pre-eclampsia. Lancet 1977; 1:923-925. (Pubitemid 8091993)
27. Lindsay MK, Graves W, Klein L. The relationship of one abnormal glucose tolerance test value and pregnancy complications. Obstet Gynecol 1989; 73:103-106. (Pubitemid 19021013)
28. Cheng YW, McLaughlin GB, Esakoff TF, Block-Kurbisch I, Caughey AB. Glucose challenge test: Screening threshold for gestational diabetes mellitus and associated outcomes. J Matern Fetal Neonatal Med 2007; 20:903-908. (Pubitemid 350207563)
29. Stamilio D, Olsen T, Ratcliffe S, Sehdev H, Macones G. False-positive 1-h glucose challenge test and adverse perinatal outcomes. Obstet Gynecol 2004; 103:148-156. (Pubitemid 39248480)
30. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352:2477-2486. (Pubitemid 41007863)
31. Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ. Factors predisposing to pre-eclampsia in women with gestational diabetes. J Hypertens 2004; 22:2371-2378. (Pubitemid 39625097)
32. Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: The impact of glycemic control. Am J Obstet Gynecol 2004; 191:1655-1660. (Pubitemid 39491193)
33. Forest JC, Girouard J, Masse J, et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005; 105:1373-1380. (Pubitemid 40734272)
34. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53:2087-2094. (Pubitemid 38970759)
35. Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: A prospective study among Japanese Americans. Diabetes Care 2000; 23:465-471. (Pubitemid 30185788)
36. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese- American Community Diabetes Study. Diabetes Care 1999; 22:1808-1812.
37. van Harmelen V, Dicker A, Ryden M, et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 2002; 51:2029-2036. (Pubitemid 34729005)
38. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 2003; 46:459-469. (Pubitemid 36577787)
39. Katsuki A, Sumida Y, Murashima S, et al. Serum levels of tumor necrosis factor-a are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83:859-862. (Pubitemid 28496458)
40. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46:860-867. (Pubitemid 27188265)
41. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81:2908-2911. (Pubitemid 26323884)
42. Wolf M, Hubel CA, Lam C, et al. Preeclampsia and future cardiovascular disease: Potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89:6239-6243. (Pubitemid 39628439)
43. Anastasiou E, Lekakis JP, Alevizaki M, et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 1998; 21:2111-2115. (Pubitemid 28549159)
44. Clark CMJ, Chunfu Q, Amerman B, et al. Gestational diabetes: Should it be added to the syndrome of insulin resistance? Diabetes Care 1997; 20:867-871.
45. Hu J, Norman M, Wallensteen M, Gennser G. Increased large arterial stiffness and impaired acetylcholine induced vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol 1998; 105:1279-1287. (Pubitemid 29002829)
46. Kautzky-Willer A, Fasching P, Jilma B, Waldhausl W, Wagner OF. Persistent elevation and metabolic dependence of circulation E-selectin after delivery in women with gestational diabetes mellitus. J Clin Endocrinol Metab 1997; 82:4117-4121. (Pubitemid 27525524)
47. Miccoli R, Volpe L, Lencioni C, et al. Insulin resistance syndrome in women with previous gestational diabetes mellitus. Diabetes 2003;52:A408.
48. Verma A, Boney CM, Tucker R, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002; 87:3227-3235. (Pubitemid 34816370)
49. Lydon-Rochelle MT, Holt VL, Cardenas V, et al. The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 2005; 193:125-134. (Pubitemid 41001326)
50. Frederick IO, Rudra CB, Miller RS, Foster JC, Williams MA. Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology 2006; 17:428-434. (Pubitemid 44305516)
51. Qiu C, Williams MA, Leisenring WM, et al. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 2003; 41:408-413. (Pubitemid 36314609)
52. Ness RB, Markovic N, Bass D, Harger G, Roberts JM. Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003; 102:1366-1371. (Pubitemid 37518420)